Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Wolfgang Bethge

Deputy Medical Director

University Hospital Tübingen

Germany

Research Interests

Explore related searches

Professors in Germany

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (15)

Alexander Kanellopoulos

University of Sheffield

UNITED KINGDOM

View details

Georg Schett

Head of Department of Medicine 3

University Hospital Erlangen

GERMANY

View details

Jakob R Passweg

Head

University Hospital Basel

SWITZERLAND

View details

Hermann Einsele

University Hospital Würzburg

GERMANY

View details

Claudia Lengerke

Vice Dean

University Hospital Tübingen

GERMANY

View details

Joerg Henes

Professor

University Hospital Tübingen

GERMANY

View details

Stephan Mielke

Professor of Hematology and Cell Therapy

Karolinska Institutet

SWEDEN

View details

Tobias Holderried

Professor of Cellular Immunotherapy

Medical University of Graz

AUSTRIA

View details

Marion Subklewe

University Hospital

GERMANY

View details

Emanuele Angelucci

Hematology and Transpalnt Center Head

Ospedale Policlinico San Martino

ITALY

View details

Alessandro Rambaldi

University of Milan

ITALY

View details

Ann-Christin Pecher

Eberhard Karls Universität Tübingen

GERMANY

View details

Robert Zeiser

Director Div. of Tumor immunology/Professor

University Medical Center Freiburg

GERMANY

View details

Marion Subklewe

LMU University Hospital

GERMANY

View details

Miroslaw Markiewicz

Head of Department

Rzeszów University

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wolfgang Bethge

Research Interests

Explore related searches

Articles (20)

Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders

Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve

Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT

Choice of a different donor reduces relapse risk after second allogeneic SCT for MDS

Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT

CD19-targeting CAR T cell therapy in five patients with systemic sclerosis unsuitable for autologous stem cell transplantation

Long-term patient-reported outcomes following allogeneic hematopoietic cell transplantation

Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Dual anti-CD19/22 and anti-BCMA CAR T-cell therapy in a patient with multiple myeloma and secondary B-ALL

Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial

Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblings

Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality

Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell Transplantation

Adenovirus‐ and cytomegalovirus‐specific adoptive T‐cell therapy in the context of hematologic cell transplant or HIV infection – A single‐center experience

Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison

Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-Analysis

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably to DLBCL: a GLA/DRST registry study

Collaborators (15)

Alexander Kanellopoulos

Georg Schett

Jakob R Passweg

Hermann Einsele

Claudia Lengerke

Joerg Henes

Stephan Mielke

Tobias Holderried

Marion Subklewe

Emanuele Angelucci

Alessandro Rambaldi

Ann-Christin Pecher

Robert Zeiser

Marion Subklewe

Miroslaw Markiewicz

Make your next move.